[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial.
about
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachDiagnostic Efficacy of Sentinel Lymph Node Biopsy in Early Oral Squamous Cell Carcinoma: A Meta-Analysis of 66 Studies.Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node BiopsyWhat is the role of sentinel lymph node biopsy in early-stage oral cavity carcinoma?Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?Treatment of head and neck cancer in the elderly.Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals.Availability of sentinel lymph node biopsy for cutaneous squamous cell carcinoma.The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer.Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.Contemporary use of sentinel lymph node biopsy in the head and neck.Technique for reliable sentinel node biopsy in squamous cell carcinomas of the floor of mouth.
P2860
Q26765937-27A75913-9723-4D8B-A6F5-FFB83097B60CQ36255860-AC486DDA-4B2A-4BEF-BA1A-C55E025E0E3AQ36391803-6E09E885-7334-4CD7-89D1-284C03B7D602Q38563579-7FDCD160-4AD1-4F1C-B452-95CD05D90870Q38755295-19EF81CE-F516-4431-834C-1B305B4DEC0DQ38958367-280CDB56-8BA7-43CE-B4F7-9DA692322CD4Q38958817-6C695BF4-68A7-4CB7-A7AB-047EDB90E209Q40566495-33F76E3E-C649-42F8-9FEB-2C6DCE46C6BAQ42290996-1D24ABAE-9756-454A-84CF-FA5A60901E9BQ46182421-4FFCAC3F-3F59-4185-9544-B1DC4237D4BBQ52858719-9567259A-7DC5-4F7D-AC1B-5ED00FEC1811Q52984029-7D9AC49B-F8F9-4E55-8C6A-F7F46F1EB337
P2860
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
[(99m)Tc]Tilmanocept Accuratel ...... III Multi-institutional Trial.
@en
type
label
[(99m)Tc]Tilmanocept Accuratel ...... III Multi-institutional Trial.
@en
prefLabel
[(99m)Tc]Tilmanocept Accuratel ...... III Multi-institutional Trial.
@en
P2093
P2860
P1476
[(99m)Tc]Tilmanocept Accuratel ...... III Multi-institutional Trial
@en
P2093
Amit Agrawal
David M Cognetti
Dennis W King
Francisco J Civantos
Karen T Pitman
Kevin T Brumund
Lori A Christman
Nathan C Hall
Robert P Zitsch
Russell B Smith
P2860
P2888
P304
P356
10.1245/S10434-015-4382-X
P577
2015-02-11T00:00:00Z
P5875
P6179
1000774195